Google
WWW CareCure Forums

Go Back   CareCure Forums > Exchange Forums > Clinical Trials

Clinical Trials Clinical trials and studies

Reply
 
Thread Tools Display Modes
Old 09-27-2001, 10:25 AM   #1
Wise Young
Administrator
 
Wise Young's Avatar
 
Join Date: Jul 2001
Location: New Brunswick, NJ, USA
Posts: 34,571
Clinical neuropharmacology of Pain in Spinal Cord Injury

http://www.centerwatch.com/patient/s.../stu28038.html

Summary: Clinical neuropharmacology of Pain in Spinal Cord Injury

Massachusetts General Hospital Department of Anesthesia is conducting a research project to evaluate investigational drugs as a treatment for specific types of pain caused by spinal cord injury (SCI).

Patient Inclusion/Exclusion Criteria:

Individuals between the ages of 18 and 70 with SCI who have had persistent pain for a minimum of 3 months following SCI may be eligible. The study requires 5 or 6 hospital visits over the course of 31 weeks.


Contact:
Kate Jenkins Research Coordinator
Massachusetts General Hospital
Fruit Street
Boston, MA 02115
Telephone: 617-724-0330
Email: PainTrials@partners.org
Wise Young is offline   Reply With Quote
Old 10-03-2001, 06:49 PM   #2
Wise Young
Administrator
 
Wise Young's Avatar
 
Join Date: Jul 2001
Location: New Brunswick, NJ, USA
Posts: 34,571
Christine N. Sang, M.D., M.P.H. at the Massachusetts General Hospital is funded by the Christopher Reeve Paralysis Foundation to study the role of glutamate receptor blockers in the treatment of central neuropathic pain in patients after spinal cord injury.

According to the new CRPF description (CRPF Progress in Research, Issue 39, Summer 2001) of the research that is being funded at MGH:

Quote:
Standard medicine offers a plethora of ineffective pharmacological interventions for the chronic pain the accompanies spnal cord injury. Dr. Sang's research seeks to identify new agents that target specific biological mechanisms underlying SCI pain. This clinical trial will test the drug LY293558, a new ANTA/KA receptor antagonist, on people with spontaneous pain and allodynia. Other ANTA/KA antagonists have proven effective against pain in animal models of injury but LY293558 is unique in its minimal side effects at doses shown to relieve the chronic pain associated with excitation of spinal cord pain-processing signals. It is hoped the trial, which uses ketamine as a positive control and a saline placebo, will improve treatment options by identifying a specific drug that tarets a particular type of central neuropathic pain.
Wise Young is offline   Reply With Quote
Old 10-22-2001, 10:58 AM   #3
Wise Young
Administrator
 
Wise Young's Avatar
 
Join Date: Jul 2001
Location: New Brunswick, NJ, USA
Posts: 34,571
This trial is also posted on http://www.spinalcord.uab.edu/show.asp?durki=43304
Wise Young is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -4. The time now is 09:13 AM.



"CC Wiki" powered by VaultWiki v2.5.0.
Copyright © 2008 - 2010, Cracked Egg Studios.